Editorial Policy

Last updated: April 29, 2026

The GLPSpot is committed to providing accurate, up-to-date, and actionable health and nutrition information for people taking GLP-1 receptor agonist medications. This page explains how we create, review, and maintain our content.

Our Editorial Mission

We write for real people navigating the practical challenges of GLP-1 medications — changes in appetite, nutrition needs, side effects, and daily routines. Our goal is to fill the gap between clinical information and everyday life with content that is honest, clear, and useful.

Content Standards

  • Accuracy first. Every claim about medications, side effects, or nutrition is based on published research, official drug labels, or established clinical guidelines. We cite primary sources wherever possible.
  • No medical advice. We provide general information, not personalized medical guidance. We always encourage readers to consult their healthcare provider for decisions about treatment, dosage, or medication changes.
  • Evidence hierarchy. We prioritize peer-reviewed studies, FDA labeling, and clinical practice guidelines over anecdotal reports. When we cite social media or community experiences, we clearly label them as such.
  • Balanced perspective. We present both benefits and risks of GLP-1 medications. We do not promote or discourage the use of any specific drug.

Medical Review

Our content is reviewed for clinical accuracy by qualified health professionals. Articles that include medical claims, dosage information, or clinical data undergo a medical review before publication. Each reviewed article displays the reviewer's name, credentials, and the date of review.

Content Review Cycle

  • Writer researches and drafts the article using primary sources.
  • Editor reviews for clarity, accuracy, and adherence to style guidelines.
  • Medical reviewer checks clinical claims, drug information, and safety content.
  • Publish. The article goes live with author and reviewer attribution.
  • Periodic updates. We revisit published articles at least every 6 months, or sooner when new research, drug approvals, or safety alerts warrant a revision.

Source Standards

We rely on the following types of sources, in order of preference:

  1. Peer-reviewed journals and systematic reviews
  2. FDA drug labels and regulatory documents
  3. Clinical practice guidelines from major medical societies
  4. Government health agencies (NIH, CDC, NIDDK)
  5. Reputable medical institutions and academic centers

We do not cite marketing materials from pharmaceutical companies as primary sources for clinical claims.

Corrections Policy

When we find an error in a published article, we correct it promptly and transparently:

  • Factual errors (wrong data, incorrect drug info) are corrected immediately. A correction notice is added at the bottom of the article with the date and description of the change.
  • Minor updates (updated pricing, new brand names) are made inline. The "Last updated" date on the article is changed.
  • Major rewrites (significant new research changing previous conclusions) result in a full article revision with a note at the top explaining what changed and why.

If you spot an error, please contact us so we can investigate and correct it.

Affiliate and Advertising Disclosure

The GLPSpot participates in affiliate programs, including Amazon Associates. Product recommendations are based on editorial judgment and reader relevance, not affiliate commission rates. Our affiliate relationships are disclosed on our Affiliate Disclosure and Ads Disclosure pages.

Content Freshness

Health information changes quickly. We monitor FDA safety communications, new clinical trials, and drug approval changes that affect our published content. Articles are reviewed on a regular cycle and updated as needed. Each article displays both the original publish date and the date of the most recent review or update.